Guideline | Drug Name |
---|---|
Botox (onabotulinumtoxinA) | Botox (onabotulinumtoxin A), Botox Cosmetic (onabotulinumtoxin A) |
Bowel Prep Agents | Moviprep, Osmoprep, Plenvu |
BPH Agents | Cardura XL (doxazosin mesylate extended-release), Entadfi (finasteride and tadalafil) |
Braftovi (encorafenib) | Braftovi (encorafenib) |
Brand Estradiol Transdermal Systems | Alora (estradiol transdermal system), Menostar (estradiol transdermal system), Minivelle (estradiol transdermal system), Vivelle-Dot (estradiol transdermal system) |
Brand Lidoderm Patch | Lidoderm (lidocaine patch 5%), Lidocan patch (lidocaine patch 5%), Brand Lidocan II patch (lidocaine patch 5%), Brand Lidocan III patch (lidocaine patch 5%), Brand Tridacaine (lidocaine patch 5%) |
Brexafemme (ibrexafungerp) | Brexafemme (ibrexafungerp) tablets |
Brineura (cerliponase alfa) | Brineura (cerliponase alfa) |
Bronchitol (mannitol) inhalation powder | Bronchitol (mannitol) inhalation powder |
Brukinsa (zanubrutinib) | Brukinsa (zanubrutinib) |
Bylvay (odevixibat) | Bylvay (odevixibat) |
Cablivi (caplacizumab-yhdp) | Cablivi (caplacizumab-yhdp) |
Cabometyx (cabozantinib) | Cabometyx (cabozantinib) tablets |
Cabotegravir Containing Agents - PA, NF | Cabenuva (cabotegravir and rilpivirine) Injection, Vocabria (cabotegravir) Tablet |
Calquence (acalabrutinib) | Calquence (acalabrutinib) |
Camzyos (mavacamten) - PA, NF | Camzyos (mavacamten) |
Cannabinoids | Marinol (dronabinol) capsule, Syndros (dronabinol) oral solution |
Caprelsa (vandetanib) | Caprelsa (vandetanib) |
Carbaglu (carglumic acid) | Carbaglu (carglumic acid) tablets for oral suspension |
Casgevy (exagamglogene autotemcel injection) | Casgevy (exagamglogene autotemcel injection) |